Overview

Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The present study will test if administration of different concentrations of 1334H eyedrops will be effective in treatment of allergic conjunctivitis in people with 10 yrs of age or older.
Phase:
Phase 2
Details
Lead Sponsor:
Sun Pharma Advanced Research Company Limited